AG
AFIB

Algert Global’s Acutus Medical Inc AFIB Stock Holding History

Algert Global’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,642
Closed -$81K – 1336
2021
Q4 		$81K Buy
23,642
+7,030
+42% +$39.6K 0.01% 926
2021
Q3 		$147K Buy
16,612
+2,552
+18% +$33.6K 0.02% 947
2021
Q2 		$239K Buy
+14,060
New +$206K 0.08% 328

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Algert Global's AFIB Position: Q1 2022 in Review

Algert Global sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 23,642 shares — an estimated $81K sold.

Algert Global first reported a position in AFIB in Q2 2021 and held it in 3 quarters. The position peaked at $239K in Q2 2021. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

  • Algert Global reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Algert Global sold 23,642 Acutus Medical Inc shares in Q1 2022, an estimated $81K.
  • Algert Global first reported a position in Acutus Medical Inc in Q2 2021 and held it in 3 quarters.
  • Algert Global's Acutus Medical Inc position peaked at $239K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.